Source: BioSpace

TUCSON, Ariz., June 17, 2020 /PRNewswire/ — Until President Trump suggested that hydroxychloroquine (HCQ, Plaquenil™) might help COVID-19 patients, it was generally considered a very safe drug, observes the Association of American Physicians & Surgeons (AAPS). It was approved by the FDA in 1955 and has been used by hundreds of millions of patients worldwide for malaria, lupus, and rheumatoid arthritis. Physicians do not generally require an electrocardiogram before prescribing it.

Apparently because of alarming media coverage, many patients are now expressing fear that HCQ is dangerous because of cardiac effects, states AAPS. Outgoing AMA president Patrice Harris, M.D., told the media that “you could lose your life.”

Widely reported studies have been stopped because of lack of benefit in seriously ill hospitalized COVID-19 patients and the occurrence of cardiac rhythm disturbances. AAPS notes the following:

  • Late in the disease, antivirals are unlikely to help because patients are dying of organ damage and blood clots, possibly due to immune overreaction.
  • The SARS-CoV-2 virus may infect the heart, and this may cause arrhythmias.
  • Doses of HCQ in some trials, such as the UK’s “Recovery” trial and the multinational World Health Organization (WHO) Solidarity trial may be toxic or even lethal, and much higher than recommended for any medical condition. The cumulative dose of this long-acting drug in the “Recovery” trial (9.6 grams) is four times as high as used in India.
  • A Brazilian study published in JAMA is being investigated by Brazilian governmental authorities for ethical reasons: investigators were giving seriously ill patients a lethal dose of chloroquine. HCQ (hydroxychloroquine) is much safer than chloroquine but like all drugs is toxic in too-high doses.

Americans are being urged to “follow the science.” But AAPS asks: “How can we trust the established authorities or prestigious journals when, in this perilous time, trials of an available, inexpensive, long-established drug appear to be designed to fail, while risking the lives of their subjects through deliberate or negligent drug overdoses?”

The Association of American Physicians and Surgeons (AAPS) has represented physicians of all specialties in all states since 1943. The AAPS motto is omnia pro aegroto, meaning everything for the patient.

Related:

WHO resumes hydroxychloroquine study for Covid-19, after confirming no safety concerns from falsified Lancet study

The Campaign Against Hydroxychloroquine (HCQ)

Association of American Physicians & Surgeons (AAPS) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine

FDA enables use of HCQ in a weird round about way – by revoking EUA. Says they never restricted it.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »